These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 25057492)
1. Mannosylated chitosan nanoparticles for delivery of antisense oligonucleotides for macrophage targeting. Asthana GS; Asthana A; Kohli DV; Vyas SP Biomed Res Int; 2014; 2014():526391. PubMed ID: 25057492 [TBL] [Abstract][Full Text] [Related]
2. Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant. Mehrabi M; Dounighi NM; Rezayat Sorkhabadi SM; Doroud D; Amani A; Khoobi M; Ajdary S; Pilehvar-Soltanahmadi Y Artif Cells Nanomed Biotechnol; 2018; 46(sup1):230-240. PubMed ID: 29260901 [TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory activity of chitosan nanoparticles carrying NF-κB/p65 antisense oligonucleotide in RAW264.7 macropghage stimulated by lipopolysaccharide. Ma L; Shen CA; Gao L; Li DW; Shang YR; Yin K; Zhao DX; Cheng WF; Quan DQ Colloids Surf B Biointerfaces; 2016 Jun; 142():297-306. PubMed ID: 26970817 [TBL] [Abstract][Full Text] [Related]
4. Mannosylated Chitosan Nanoparticles Based Macrophage-Targeting Gene Delivery System Enhanced Cellular Uptake and Improved Transfection Efficiency. Peng Y; Yao W; Wang B; Zong L J Nanosci Nanotechnol; 2015 Apr; 15(4):2619-27. PubMed ID: 26353473 [TBL] [Abstract][Full Text] [Related]
5. Effects of mannose density on in vitro and in vivo cellular uptake and RNAi efficiency of polymeric nanoparticles. Chu S; Tang C; Yin C Biomaterials; 2015 Jun; 52():229-39. PubMed ID: 25818429 [TBL] [Abstract][Full Text] [Related]
6. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells. Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123 [TBL] [Abstract][Full Text] [Related]
7. Development and optimization of curcumin-loaded mannosylated chitosan nanoparticles using response surface methodology in the treatment of visceral leishmaniasis. Chaubey P; Patel RR; Mishra B Expert Opin Drug Deliv; 2014 Aug; 11(8):1163-81. PubMed ID: 24875148 [TBL] [Abstract][Full Text] [Related]
8. Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages. Zeng Z; Liu Y; Wen Q; Li Y; Yu J; Xu Q; Wan W; He Y; Ma C; Huang Y; Yang H; Jiang O; Li F Drug Deliv; 2021 Dec; 28(1):943-956. PubMed ID: 33988472 [TBL] [Abstract][Full Text] [Related]
9. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting. Jiang HL; Kim YK; Arote R; Jere D; Quan JS; Yu JH; Choi YJ; Nah JW; Cho MH; Cho CS Int J Pharm; 2009 Jun; 375(1-2):133-9. PubMed ID: 19481699 [TBL] [Abstract][Full Text] [Related]
10. Urocanic acid-modified chitosan nanoparticles can confer anti-inflammatory effect by delivering CD98 siRNA to macrophages. Xiao B; Ma P; Viennois E; Merlin D Colloids Surf B Biointerfaces; 2016 Jul; 143():186-193. PubMed ID: 27011348 [TBL] [Abstract][Full Text] [Related]
11. Mannosylated polyethylenimine coupled mesoporous silica nanoparticles for receptor-mediated gene delivery. Park IY; Kim IY; Yoo MK; Choi YJ; Cho MH; Cho CS Int J Pharm; 2008 Jul; 359(1-2):280-7. PubMed ID: 18490119 [TBL] [Abstract][Full Text] [Related]
12. Mannose-anchored quaternized chitosan/thiolated carboxymethyl chitosan composite NPs as mucoadhesive carrier for drug delivery. Jin Z; Hu G; Zhao K Carbohydr Polym; 2022 May; 283():119174. PubMed ID: 35153010 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of antisense oligonucleotide loaded chitosan nanoparticles; characterization and antisense effect. Ozbaş-Turan S; Akbuğa J; Enneli B Pharmazie; 2009 Dec; 64(12):807-11. PubMed ID: 20095138 [TBL] [Abstract][Full Text] [Related]
15. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. Chaubey P; Mishra B Carbohydr Polym; 2014 Jan; 101():1101-8. PubMed ID: 24299880 [TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
17. Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery. Alameh M; Dejesus D; Jean M; Darras V; Thibault M; Lavertu M; Buschmann MD; Merzouki A Int J Nanomedicine; 2012; 7():1399-414. PubMed ID: 22457597 [TBL] [Abstract][Full Text] [Related]
18. Thiolated carboxymethyl dextran as a nanocarrier for colon delivery of hSET1 antisense: In vitro stability and efficiency study. Kiani M; Mirzazadeh Tekie FS; Dinarvand M; Soleimani M; Dinarvand R; Atyabi F Mater Sci Eng C Mater Biol Appl; 2016 May; 62():771-8. PubMed ID: 26952483 [TBL] [Abstract][Full Text] [Related]